Resorption von Ferritin im proximalen Konvolut der Rattenniere (nach intratubulärer Applikation durch Mikropunktion)

W. Thoenes,K. H. Langér,M. Wiederholt

DOI: https://doi.org/10.1007/BF01747899

1966-12-01

Klinische Wochenschrift

Abstract:

What problem does this paper attempt to address?

A 1H Magnetic Resonance Spectroscopy Imaging Study on Prefrontal and Hippocampus in Patients with Depression

林铮,李惠春,龚向阳,卢蕴容,俞少华,禹华良,陈巧珍

DOI: https://doi.org/10.3760/j:issn:1006-7884.2005.04.001

2005-01-01

Abstract:Objective To identify the possible alterations of brain functioning in prefrontal lobe and hippocampus in patients with depression using proton magnetic resonance spectroscopy (1H-MRS).Methods 1H-MRS was performed on prefrontal lobe and hippocampus in 26 patients with depression and 20 control. The median age of patients was 38.5 years. The patients were divided into the elder group [ (54±9)years old,n=12] or the younger group [(28±7)years old, n=14]. The patients were also separated into two groups according the illness duration, i.e., the first-episode group (19 cases) and recurrent group (7 cases).The NAA, Cho and Cr were measured and the ratios of NAA/Cr and Cho/Cr were determined.Results The Cho/Cr ratios in left prefrontal lobe in elder patients and right prefrontal in younger patients were higher than that in normal controls (left: P0.05,right: P0.01), respectively. In left hippocampus, the NAA/Cr ratio in elder patients was lower than that in controls (P0.01) while the Cho/Cr in younger patients higher than that in controls (P0.05). The Cho/Cr ratios in left prefrontal lobe of first-episode patients and right prefrontal lobe of recurrent patients were higher than that in controls (first-episode: P0.01; recurrent: P0.01). The NAA/Cr ratios in left hippocampus of first-episode patients and recurrent patients were lower than that in controls (P0.01). And the Cho/Cr ratio in right hippocampus of recurrent patients was higher than that in controls(P0.01).Conclusion There might exist both abnormal turnover of membrane in prefrontal lobe and left hippocampus in patients with depression and reduced neuronal function in left hippocampus of the elder patients.
Correlation of neurochemical metabolism with memory function in young adult patients with first-episode depression studied with proton magnetic resonance spectroscopy]

Weibo Liu,Hualiang Yu,Biao Jiang,Leilei Zheng,Shaohua Yu,Bing Pan,Risheng Yu

DOI: https://doi.org/10.3785/j.issn.1008-9292.2013.04.013

2013-01-01

Abstract:To investigate the correlation of neurochemical metabolism in hippocampus with memory function in young adult patients with first-episode depression.Twenty patients with first-episode depression (patient group) and fifteen health subjects (control group) were enrolled in the study. The neurochemical metabolism, including the levels of N-acetylaspartate (NAA), Choline (Cho), Creatine (Cr), Myoinositol (mI) were measured by proton magnetic resonance spectroscope (1H-MRS) in bilateral hippocampus. Wechsler Memory Scale (WMS) were used to examine the memory function in both groups.The memory quotient (89.15 ±6.62) of patient group was significantly lower than that of controls (P <0.01),the scores of long-term memory,short-term memory and immediate memory in patients were also lower than those of controls (P<0.05 or 0.01). In patient group, the ratio of NAA/Cr (1.34 ±0.08) in the left hippocampus was significantly lower than that of control group (P<0.01); and the ratio of mI/Cr in the bilateral hippocampus [(0.63 ±0.13) in left and (0.6 ±0.1) in right] was significantly higher than those in control group (P<0.05). In patient group,the ratio of NAA/Cr in the left hippocampus was positively correlated with WMS scores (P<0.01), and the ratio of mI/Cr in the left hippocampus was negatively correlated with WMS scores (P<0.05).The memory deficit and abnormal metabolism function of neuron cell in hippocampus coexist in young adult patients with first-episode depression, and the lower NAA/Cr and higher mI/Cr ratio in the left hippocampus may result in the memory deficit.
Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy

Yan Li,Chen Cheng Zhang,Kathrin Weidacker,Yingying Zhang,Naying He,Haiyan Jin,Weibo Chen,Valerie Voon,Richard A. E. Edden,Fuhua Yan

DOI: https://doi.org/10.1186/s12888-019-2160-1

IF: 4.144

2019-05-30

BMC Psychiatry

Abstract:BackgroundObsessive-compulsive disorder (OCD) is a relatively common and disabling psychiatric disorder whose pathophysiology is incompletely understood. In this study, we utilized magnetic resonance spectroscopy (MRS) in an effort to provide a better understanding of the role of brain gamma-aminobutyric acid (GABA) and glutamate in the pathophysiology of OCD. We hypothesized that beyond the separate effects of these neurotransmitter systems, a disruption in the balance between GABA and glutamate could be particularly relevant to OCD.MethodsWe obtained MRS measures of GABA and glutamate concentrations in the anterior cingulate cortex from 23 adult patients with OCD and 20 sex- and age-matched healthy community volunteers. Established clinical rating scales were used to assess the severities of OCD, anxiety, and depression symptoms. Statistical analysis involved the assessment of patient-control group differences in the individual measures of GABA and glutamate, as well as in the ratio of the GABA to glutamate measures. Additionally, we explored whether differences in the MRS measures existed between two subgroups of patients formed according to the severity of their OCD symptoms. Finally, we assessed the relations of demographic and clinical variables to the MRS measures.ResultsPatients with OCD displayed a higher estimated GABA level and a higher GABA to glutamate ratio than healthy participants, but no significant group differences were observed in the measure of glutamate. The MRS measures did not vary by subgroup and showed no correlations with demographic and clinical variables.ConclusionsThese results indicate that GABA abnormalities within the anterior cingulate cortex contribute to the pathophysiology of OCD. The results fail to provide evidence that glutamate abnormalities alone are involved in adult OCD. Yet, it seems that a disruption in the balance between glutamate and GABA neurotransmission may have a particularly important role to play in OCD pathophysiology.

psychiatry
Plasma oxidative stress marker levels related to functional brain abnormalities in first-episode drug-naive major depressive disorder

Yuan Liu,Bin Zhang,Yuwen Zhou,Meijuan Li,Ying Gao,Wen Qin,Yingying Xie,Weigang Liu,Yifan Jing,Jie Li

DOI: https://doi.org/10.1016/j.psychres.2024.115742

IF: 11.3

2024-03-01

Psychiatry Research

Abstract:Major Depressive Disorder (MDD) is marked by abnormal brain function and elevated plasma oxidative stress markers. The specific relationship between these factors in MDD remains unclear. In this study, we conducted resting-state fMRI scans on fifty-seven first-episode, drug-naive MDD patients and sixty healthy controls. Plasma levels of oxidative stress markers (superoxide dismutase (SOD) and glutathione reductase (GSR)) were assessed using ELISA. Our results revealed a positive correlation between plasma SOD and GSR levels in MDD patients and the amplitude of low-frequency fluctuation (ALFF) values in key brain regions-thalamus, anterior cingulate gyrus, and superior frontal gyrus. Further analysis indicated positive correlations between plasma SOD and GSR levels and specific ALFF values in MDD patients without suicidal ideation, with these correlations not significant in MDD patients with suicidal ideation. Additionally, seed-based whole-brain functional connectivity analysis demonstrated a negative correlation between plasma GSR levels and connectivity between the thalamus and insula, while plasma SOD levels showed a positive correlation with connectivity between the thalamus and precuneus. These findings contribute to our understanding of MDD's pathophysiology and heterogeneity, highlighting the association between plasma oxidative stress markers and functional abnormalities in diverse brain regions.

psychiatry
A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia

Jennifer M. Coughlin,Kun Yang,Anouk Marsman,Subechhya Pradhan,Min Wang,Rebecca E. Ward,Susanne Bonekamp,Emily B. Ambinder,Cecilia P. Higgs,Pearl K. Kim,Jamie A. Edwards,Mark Varvaris,Hongxing Wang,Sotirios Posporelis,Shuangchao Ma,Tsuyoshi Tsujimura,Richard A. E. Edden,Martin G. Pomper,Thomas W. Sedlak,Margot Fournier,David J. Schretlen,Nicola G. Cascella,Peter B. Barker,Akira Sawa

DOI: https://doi.org/10.1038/s41380-020-00901-5

IF: 11

2020-10-19

Molecular Psychiatry

Abstract:Involvement of oxidative stress in the pathophysiology of schizophrenia (SZ) is suggested by studies of peripheral tissue. Nonetheless, it is unclear how such biological changes are linked to relevant, pathological neurochemistry, and brain function. We designed a multi-faceted study by combining biochemistry, neuroimaging, and neuropsychology to test how peripheral changes in a key marker for oxidative stress, glutathione (GSH), may associate with central neurochemicals or neuropsychological performance in health and in SZ. GSH in dorsal anterior cingulate cortex (dACC) was acquired as a secondary 3T <sup>1</sup>H-MRS outcome using a MEGA-PRESS sequence. Fifty healthy controls and 46 patients with SZ were studied cross-sectionally, and analyses were adjusted for effects of confounding variables. We observed lower peripheral total GSH in SZ compared to controls in extracellular (plasma) and intracellular (lymphoblast) pools. Total GSH levels in plasma positively correlated with composite neuropsychological performance across the total population and within patients. Total plasma GSH levels were also positively correlated with the levels of Glx in the dACC across the total population, as well as within each individual group (controls, patients). Furthermore, the levels of dACC Glx and dACC GSH positively correlated with composite neuropsychological performance in the patient group. Exploring the relationship between systemic oxidative stress (in particular GSH), central glutamate, and cognition in SZ will benefit further from assessment of patients with more varied neuropsychological performance.

biochemistry & molecular biology,neurosciences,psychiatry
Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task

Reggie Taylor,Richard W J Neufeld,Betsy Schaefer,Maria Densmore,Nagalingam Rajakumar,Elizabeth A Osuch,Peter C Williamson,Jean Théberge

DOI: https://doi.org/10.1038/npjschz.2015.28

2015-09-16

Abstract:Background:Glutamate abnormalities have been suggested to be associated with symptoms of schizophrenia. Using functional magnetic resonance spectroscopy (1H-fMRS), it is possible to monitor glutamate dynamically in the activated brain areas, which has yet to be reported in schizophrenia. It was hypothesized that subjects with schizophrenia would have weaker glutamatergic responses in the anterior cingulate to a color-word Stroop Task.AIMS:The aim of this study was to gain insight into the health of GLU neurotransmission and the GLU-GLN cycle in SZ using a 1H-fMRS protocol.Methods:Spectra were acquired from the anterior cingulate of 16 participants with schizophrenia, 16 healthy controls and 16 participants with major depressive disorder (MDD) while performing the Stroop task in a 7T magnetic resonance imaging scanner. 1H-fMRS spectra were acquired for 20 min in which there were three 4-min blocks of cross fixation interleaved with two 4-min blocks of the Stroop paradigm.Results:A repeated-measures analysis of variance revealed a main effect of time for glutamate concentrations of all groups (P<0.001). The healthy control group increased glutamate concentrations in the first run of the Stroop task (P=0.006) followed by a decrease in the recovery period (P=0.007). Neither the schizophrenia (P=0.107) nor MDD (P=0.081) groups had significant glutamate changes in the first run of the task, while the schizophrenia group had a significant increase in glutamine (P=0.005). The MDD group decreased glutamate concentrations in the second run of the task (P=0.003), as did all the groups combined (P=0.003).Conclusions:1H-fMRS data were successfully acquired from psychiatric subjects with schizophrenia and mood disorder using a cognitive paradigm for the first time. Future study designs should further elucidate the glutamatergic response to functional activation in schizophrenia.

psychiatry
Reduction of higher-order occipital GABA and impaired visual perception in acute major depressive disorder

Xue Mei Song,Xi-Wen Hu,Zhe Li,Yuan Gao,Xuan Ju,Dong-Yu Liu,Qian-Nan Wang,Chuang Xue,Yong-Chun Cai,Ruiliang Bai,Zhong-Lin Tan,Georg Northoff

DOI: https://doi.org/10.1038/s41380-021-01090-5

IF: 11

2021-04-16

Molecular Psychiatry

Abstract:Abstract Major depressive disorder (MDD) is a complex state-dependent psychiatric illness for which biomarkers linking psychophysical, biochemical, and psychopathological changes remain yet elusive, though. Earlier studies demonstrate reduced GABA in lower-order occipital cortex in acute MDD leaving open its validity and significance for higher-order visual perception, though. The goal of our study is to fill that gap by combining psychophysical investigation of visual perception with measurement of GABA concentration in middle temporal visual area (hMT+) in acute depressed MDD. Psychophysically, we observe a highly specific deficit in visual surround motion suppression in a large sample of acute MDD subjects which, importantly, correlates with symptom severity. Both visual deficit and its relation to symptom severity are replicated in the smaller MDD sample that received MRS. Using high-field 7T proton Magnetic resonance spectroscopy ( 1 H-MRS), acute MDD subjects exhibit decreased GABA concentration in visual MT+ which, unlike in healthy subjects, no longer correlates with their visual motion performance, i.e., impaired SI. In sum, our combined psychophysical-biochemical study demonstrates an important role of reduced occipital GABA for altered visual perception and psychopathological symptoms in acute MDD. Bridging the gap from the biochemical level of occipital GABA over visual-perceptual changes to psychopathological symptoms, our findings point to the importance of the occipital cortex in acute depressed MDD including its role as candidate biomarker.

biochemistry & molecular biology,neurosciences,psychiatry
Myo-inositol, Glutamate, and Glutamine in the Prefrontal Cortex, Hippocampus, and Amygdala in Major Depression

Yukihiko Shirayama,Michio Takahashi,Fumio Osone,Akira Hara,Toshiyuki Okubo

DOI: https://doi.org/10.1016/j.bpsc.2016.11.006

Abstract:Background: The brains of patients with depression exhibit many changes in various regions. Recently, proton magnetic resonance spectroscopy has been used to measure brain metabolites, using saturation bands to shape the volume of interest. Our a priori hypothesis was that myo-inositol and glutamate were downregulated in the hippocampus and amygdala in depression. Methods: We measured brain metabolites from the medial prefrontal cortex, hippocampus, and amygdala of 22 drug-naïve, first-episode patients with major depressive disorder and 27 healthy control subjects using 3T proton magnetic resonance spectroscopy. Results: Compared with healthy control subjects, patients showed statistically significant reductions in myo-inositol levels in all three regions and reductions in glutamate levels in the medial prefrontal cortex. Furthermore, we found significant decreases in the ratios of glutamate to creatine plus phosphocreatine in the medial prefrontal cortex and amygdala. Additionally, the ratios of glutamine to creatine plus phosphocreatine were also decreased in all three regions examined, although not all the participants presented reliable data. Finally, glutamate levels in the medial prefrontal cortex and amygdala have significant correlations with executive function and those in the hippocampus with memory function. Hippocampal myo-inositol was significantly related to blood cortisol. Conclusions: Our findings indicated abnormal myo-inositol, glutamate, and glutamine levels in the brains of major depressive disorder patients.
Plasma metabolites were associated with spatial working memory in major depressive disorder

Yue Du,Jinxue Wei,Xiao Yang,Yikai Dou,Liansheng Zhao,Xueyu Qi,Xueli Yu,Wanjun Guo,Qiang Wang,Wei Deng,Minli Li,Dongtao Lin,Tao Li,Xiaohong Ma

DOI: https://doi.org/10.1097/MD.0000000000024581

IF: 1.6

2021-01-01

Medicine

Abstract:Major depressive disorder (MDD) is a common disease with both affective and cognitive disorders. Alterations in metabolic systems of MDD patients have been reported, but the underlying mechanisms still remains unclear. We sought to identify abnormal metabolites in MDD by metabolomics and to explore the association between differential metabolites and neurocognitive dysfunction. Plasma samples from 53 MDD patients and 83 sex-, gender-, BMI-matched healthy controls (HCs) were collected. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) system was then used to detect metabolites in those samples. Two different algorithms were applied to identify differential metabolites in 2 groups. Of the 136 participants, 35 MDD patients and 48 HCs had completed spatial working memory test. Spearman rank correlation coefficient was applied to explore the relationship between differential metabolites and working memory in these 2 groups. The top 5 metabolites which were found in sparse partial least squares-discriminant analysis (sPLS-DA) model and random forest (RF) model were the same, and significant difference was found in 3 metabolites between MDD and HCs, namely, gamma-glutamyl leucine, leucine-enkephalin, and valeric acid. In addition, MDD patients had higher scores in spatial working memory (SWM) between errors and total errors than HCs. Valeric acid was positively correlated with working memory in MDD group. Gamma-glutamyl leucine, leucine-enkephalin, and valeric acid were preliminarily proven to be decreased in MDD patients. In addition, MDD patients performed worse in working memory than HCs. Dysfunction in working memory of MDD individuals was associated with valeric acid.
Glutathione and glutamate in schizophrenia: a 7T MRS study

Jyothika Kumar,Elizabeth B. Liddle,Carolina C. Fernandes,Lena Palaniyappan,Emma L. Hall,Siân E. Robson,Molly Simmonite,Jan Fiesal,Mohammad Z. Katshu,Ayaz Qureshi,Michael Skelton,Nikolaos G. Christodoulou,Matthew J. Brookes,Peter G. Morris,Peter F. Liddle

DOI: https://doi.org/10.1038/s41380-018-0104-7

IF: 11

2018-06-22

Molecular Psychiatry

Abstract:In schizophrenia, abnormal neural metabolite concentrations may arise from cortical damage following neuroinflammatory processes implicated in acute episodes. Inflammation is associated with increased glutamate, whereas the antioxidant glutathione may protect against inflammation-induced oxidative stress. We hypothesized that patients with stable schizophrenia would exhibit a reduction in glutathione, glutamate, and/or glutamine in the cerebral cortex, consistent with a post-inflammatory response, and that this reduction would be most marked in patients with “residual schizophrenia”, in whom an early stage with positive psychotic symptoms has progressed to a late stage characterized by long-term negative symptoms and impairments. We recruited 28 patients with stable schizophrenia and 45 healthy participants matched for age, gender, and parental socio-economic status. We measured glutathione, glutamate and glutamine concentrations in the anterior cingulate cortex (ACC), left insula, and visual cortex using 7T proton magnetic resonance spectroscopy (MRS). Glutathione and glutamate were significantly correlated in all three voxels. Glutamine concentrations across the three voxels were significantly correlated with each other. Principal components analysis (PCA) produced three clear components: an ACC glutathione–glutamate component; an insula-visual glutathione–glutamate component; and a glutamine component. Patients with stable schizophrenia had significantly lower scores on the ACC glutathione–glutamate component, an effect almost entirely leveraged by the sub-group of patients with residual schizophrenia. All three metabolite concentration values in the ACC were significantly reduced in this group. These findings are consistent with the hypothesis that excitotoxicity during the acute phase of illness leads to reduced glutathione and glutamate in the residual phase of the illness.

biochemistry & molecular biology,neurosciences,psychiatry
Identification of neurotransmitter imbalances in the cingulate cortex of NMOSD patients using magnetic resonance spectroscopy

Min Zhao,Xiao Li,Fuyan Li,Xin Hu,Jing Wang,Yuxi Liu,Chuanchen Zhang,Jie Bai,Richard A E Edden,Fei Gao,Meixia Su,Fuxin Ren

DOI: https://doi.org/10.1093/cercor/bhae304

IF: 4.861

2024-07-30

Cerebral Cortex

Abstract:Cognitive impairment affects 29–67% of patients with neuromyelitis optica spectrum disorder. Previous studies have reported glutamate homeostasis disruptions in astrocytes, leading to imbalances in gamma-aminobutyric acid levels. However, the association between these neurotransmitter changes and cognitive deficits remains inadequately elucidated. Point RESolved Spectroscopy and Hadamard Encoding and Reconstruction of MEGA-Edited Spectroscopy techniques were utilized to evaluate gamma-aminobutyric acid, glutamate, glutathione levels, and excitation/inhibition balance in the anterior cingulate cortex, posterior cingulate cortex, and occipital cortex of 39 neuromyelitis optica spectrum disorder patients and 41 healthy controls. Cognitive function was assessed using neurocognitive scales. Results showed decreased gamma-aminobutyric acid levels alongside increased glutamate, glutathione, and excitation/inhibition ratio in the anterior cingulate cortex and posterior cingulate cortex of neuromyelitis optica spectrum disorder patients. Specifically, within the posterior cingulate cortex of neuromyelitis optica spectrum disorder patients, decreased gamma-aminobutyric acid levels and increased excitation/inhibition ratio correlated significantly with anxiety scores, whereas glutathione levels predicted diminished executive function. The results suggest that neuromyelitis optica spectrum disorder patients exhibit dysregulation in the GABAergic and glutamatergic systems in their brains, where the excitation/inhibition imbalance potentially acts as a neuronal metabolic factor contributing to emotional disorders. Additionally, glutathione levels in the posterior cingulate cortex region may serve as predictors of cognitive decline, highlighting the potential benefits of reducing oxidative stress to safeguard cognitive function in neuromyelitis optica spectrum disorder patients.

neurosciences
Cortical Glutamate and GABA Are Related to Compulsive Behaviour in Individuals with Obsessive Compulsive Disorder and Healthy Controls

Marjan Biria,Paula Banca,Máiréad P. Healy,Engin Keser,Stephen J. Sawiak,Christopher T. Rodgers,Catarina Rua,Ana Maria Frota Lisbôa Pereira de Souza,Aleya A. Marzuki,Akeem Sule,Karen D. Ersche,Trevor W. Robbins

DOI: https://doi.org/10.1038/s41467-023-38695-z

IF: 16.6

2023-01-01

Nature Communications

Abstract:There has been little analysis of neurochemical correlates of compulsive behaviour to illuminate its underlying neural mechanisms. We use 7-Tesla proton magnetic resonance spectroscopy (1H-MRS) to assess the balance of excitatory and inhibitory neurotransmission by measuring glutamate and GABA levels in anterior cingulate cortex (ACC) and supplementary motor area (SMA) of healthy volunteers and participants with Obsessive-Compulsive Disorder (OCD). Within the SMA, trait and clinical measures of compulsive behaviour are related to glutamate levels, whereas a behavioural index of habitual control correlates with the glutamate:GABA ratio. Participants with OCD also show the latter relationship in the ACC while exhibiting elevated glutamate and lower GABA levels in that region. This study highlights SMA mechanisms of habitual control relevant to compulsive behaviour, common to the healthy sub-clinical and OCD populations. The results also demonstrate additional involvement of anterior cingulate in the balance between goal-directed and habitual responding in OCD.
0130 Central and Peripheral Markers of Oxidative Stress and Sleep in Mood Disorder: A Pilot MR Spectroscopy Study

Jessica Busler,Leilah Grant,Vicky Liao,Alexander Lin,Shadab Rahman,Pamela Mahon

DOI: https://doi.org/10.1093/sleep/zsac079.128

IF: 6.313

2022-06-04

SLEEP

Abstract:IntroductionSleep disturbance is both a symptom of and a risk factor for mood disorders. Oxidative stress may impact the relationship between sleep disturbance and mood. However, the relationships between sleep and in vivo measurements of oxidative stress in the brain have not been examined in humans. Therefore, we tested the relationship between patient-reported sleep disturbance with peripheral and central concentrations of glutathione (GSH), the primary antioxidant in the brain.MethodsParticipants (2 women and 7 men) were individuals with (n=2) and without mood disorder (n=7), ages 35-61 years. MR spectroscopy at 7 Tesla (TE=20ms, TM=10ms, TR=3000ms) was used to measure cortical GSH levels in the brain in the anterior cingulate cortex (ACC), ventromedial prefrontal cortex (VMPFC), and dorsolateral prefrontal cortex (DLPFC). Peripheral GSH was assayed from a fasted morning blood draw. Sleep disturbance and related impairment was assessed via the PROMIS Sleep Disturbance (PROMIS-SD) and Sleep-Related Impairment (PROMIS-SRI) questionnaires. Pearson correlations were assessed between peripheral and central GSH levels with PROMIS-SD and PROMIS-SRI T-scores.ResultsWe observed significant negative correlations between DLPFC GSH with sleep disturbance (r=-0.744, p=0.022) and sleep-related impairment (r=-0.753, p=0.019). We did not detect correlations between sleep-related endpoints and peripheral GSH levels or GSH levels in the ACC or VMPFC.ConclusionThese preliminary results suggest that more sleep disturbance and related impairment may be associated with lower levels of cortical GSH and implicate a role for sleep disturbance to impact oxidative stress in a region associated with rapid eye movement sleep and modulation of affective states.Support (If Any)This work was supported by grants from the National Institutes of Health R01MH110979 (PBM) and T32MH017119 (JB).

neurosciences,clinical neurology
The impact of matching for reproductive status on the comparison of magnetic spectroscopic measurements of glutamate and gamma-aminobutyric acid + in the medial prefrontal cortex of women with major depression

Kim H. Tran,Jessica Luki,Sarah Hanstock,Christopher C. Hanstock,Peter Seres,Katherine Aitchison,Tami Shandro,Jean-Michel Le Melledo

DOI: https://doi.org/10.1016/j.jad.2024.01.140

IF: 6.533

2024-02-05

Journal of Affective Disorders

Abstract:Objectives The role played by medial prefrontal cortex (MPFC) glutamate (Glu) and gamma-aminobutyric acid (GABA) in the pathophysiology and the treatment of major depression (MD) is increasingly recognized. Although measurements of MPFC GABA and Glu have been shown to be sensitive to physiological fluctuations of female hormones, none of the magnetic resonance spectroscopy (MRS) investigations of MPFC Glu and GABA in MD have controlled for possible bias effect of the reproductive stage of the women included. Methods MPFC Glu and GABA+ (which include homocarnosine and macromolecules) referenced to creatine and phosphocreatine, were measured via magnetic resonance spectroscopy (MRS) using a 3-Tesla magnet in 24 women with MD and 24 healthy women paired for reproductive status. All participants were unmedicated. Results There were no statistical differences in either MPFC Glu [95 % CI: (−0.025, 0.034)] or MPFC GABA+ [95 % CI: (−0.005, 0.017)] between women with MD and healthy controls. Conclusions Our investigation does not support abnormalities in measurement of MPFC Glu and GABA in MD women when stringent control for reproductive status is performed. As a result of the inherent limitations of MRS methodology, our results do not preclude glutamatergic and GABAergic dysregulations in the MPFC of women with MD.

psychiatry,clinical neurology
Cognitive dysfunction and neurometabolic alternations in major depressive disorder with gastrointestinal symptoms

Xiaosi Huang,Shunkai Lai,Xiaodan Lu,Ying Wang,Yiliang Zhang,Guanmao Chen,Pan Chen,Kaiwei Ye,Manying Duan,Kailin Song,Shuming Zhong,Yanbin Jia

DOI: https://doi.org/10.1016/j.jad.2022.10.036

IF: 6.533

2022-11-13

Journal of Affective Disorders

Abstract:Background Brain biochemical abnormalities have been associated with major depressive disorder (MDD) and cognitive impairments. However, the cognitive performance and neurometabolic alterations of MDD patients accompanied by gastrointestinal (GI) symptoms remain to be elucidated. We aimed to reveal the features and correlation between cognitive impairments and brain biochemical abnormalities of depressed patients with GI symptoms. Methods Fifty MDD patients with GI symptoms (GI group), 46 patients without GI symptoms (NGI group) and 50 demographically matched healthy controls (HCs) underwent Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) assessments. In addition, proton magnetic resonance spectroscopy ( 1 H-MRS) was used to obtain ratios of N -acetyl aspartate to creatine (NAA/Cr) and choline-containing compounds to creatine (Cho/Cr) in the thalamus, putamen and anterior cingulate cortex (ACC). Finally, association analysis was conducted to investigate the relationships of these measurements. Results Compared to HCs, participants in both the GI and NGI groups had significantly reduced performance in the six MCCB cognitive domains (all p < 0.05), except for reasoning and problem solving. Higher Cho/Cr ratios in the right thalamus ( p < 0.05) and lower NAA/Cr ratios in the left putamen ( p < 0.05) were found in the NGI group than in the GI group. The severity of GI symptoms was negatively correlated with Cho/Cr ratios in the right ACC ( r = −0.288, p = 0.037). In addition, the T-scores of visual learning were negatively correlated with NAA/Cr ratios in the right ACC ( r = −0.443, p = 0.001) and right thalamus ( r = −0.335, p = 0.015). Conclusion Our findings suggest that MDD patients with GI symptoms may exhibit greater neurometabolic alternations than those without GI symptoms, while both show similar cognitive dysfunction. In addition, neurometabolic alterations in the ACC and thalamus may underlie the neural basis of GI symptoms and cognitive impairment in MDD.

psychiatry,clinical neurology
Awakening to the occupational health problems.

S. Joshi

2005-07-01

Kathmandu University Medical Journal

Abstract:
Relationships between diabetes and cognitive impairment.

S. M. de la Monte

DOI: https://doi.org/10.1016/j.ecl.2013.09.006

2014-03-01

Abstract:
Resting state and activated brain glutamate–glutamine, brain lactate, cognition, and psychopathology among males with schizophrenia: A 3 Tesla proton magnetic resonance spectroscopic (1H-MRS) study

Ujjwal Singh,Basudeb Das,Sourav Khanra,Chandramouli Roy

DOI: https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_621_23

2024-01-01

Indian Journal of Psychiatry

Abstract:Background: Research on glutamate (Glu) in schizophrenia has so far been inconclusive. Based on preclinical studies on Glu lactate interaction, researchers have now focused on brain lactate level as a sign of major pathology, including cognitive dysfunctions in the brain. Our study aimed to examine changes at resting and activated states in brain lactate and Glu–glutamine (Glx) at the anterior cingulate cortex (ACC) in schizophrenia. Methods: A hospital-based prospective study was conducted with twenty-two male cases of schizophrenia and matched healthy controls (HCs). Positive and Negative Syndrome Scale (PANSS), Montreal Cognitive Assessment (MoCA), and Stroop tasks were administered among patients. Brain lactate and Glx at ACC were measured at resting state and during the Stroop test with proton magnetic resonance spectroscopy (1H-MRS) both at baseline and at remission and once among HC. Result: Though MoCA scores improved significantly ( P < 0.001) at remission from baseline among cases, repeated-measures analysis of variance (RM-ANOVA) did not find a significant time effect for Glx ( P = 0.82) and lactate ( P = 0.30) among cases from baseline to remission. Glx and lactate changed differently from baseline to remission. Conclusion: Our study did not find significant differences in Glx and lactate between schizophrenia patients and HC. No significant time effect on Glx and lactate was observed from baseline to remission among schizophrenia cases. Different changes observed in Glx and lactate from baseline to remission require replication in future studies with larger sample size, longer follow-up period, and multivoxel MR assessment.

psychiatry
Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder

Yifan Wu,Lingtao Kong,Anqi Yang,Kaiqi Xin,Yihui Lu,Xintong Yan,Wen Liu,Yue Zhu,Yingrui Guo,Xiaowei Jiang,Yifang Zhou,Qikun Sun,Yanqing Tang,Feng Wu

DOI: https://doi.org/10.1016/j.nicl.2023.103341

Abstract:Background: Major depressive disorder (MDD) is a severe mental disorder characterized by reduced gray matter volume (GMV). To date, the pathogenesis of MDD remains unclear, but neurotrophic factors play an essential role in the pathophysiological alterations of MDD during disease development. In particular, plasma glial cell line-derived neurotrophic factor (GDNF) has been suggested as a potential biomarker that may be associated with disease activity and neurological progression in MDD. Our study investigated whether plasma GDNF levels in MDD patients and healthy controls (HCs) are correlated with GMV alterations. Methods: We studied 54 MDD patients and 48 HCs. The effect of different diagnoses on whole-brain GMV was investigated using ANOVA (Analysis of Variance). The threshold of significance was p < 0.05, and Gaussian random-field (GRF) correction for error was used. All analyses were controlled for covariates such as ethnicity, handedness, age, and gender that could affect GMV. Result: Compared with the HC group, the GMV in the MDD group was significantly reduced in the right inferior orbitofrontal cortex (OFC), and plasma GDNF levels were significantly higher in the MDD group than in the HC group. In the right inferior OFC, the GDNF levels were positively correlated with GMV reduction in the MDD group, whereas in the HC group, a negative correlation was observed between GDNF levels and GMV reduction. Conclusion: Although increased production of GDNF in MDD may help repair neural damage in brain regions associated with brain disease, its repairing effects may be interfered with and hindered by underlying neuroinflammatory processes.
Neurobehavioral and Neurochemical Basis of Compulsive Behavior: A 7T Magnetic Resonance Spectroscopy Study in Humans

Marjan Biria,Paula Banca,Mairead Healy,Engin Keser,Stephen Sawiak,Ana Maria Frota Lisbôa Pereira de Souza,Aleya Marzuki,Akeem Sule,Karen Ersche,Trevor Robbins

DOI: https://doi.org/10.21203/rs.3.rs-2152573/v1

2022-01-01

Abstract:Abstract There has been relatively little analysis of possible neurochemical correlates of compulsive behavior to illuminate its underlying neural mechanisms. We utilised 7-Tesla proton magnetic resonance spectroscopy (1H-MRS) to assess the balance of excitatory and inhibitory neurotransmission by measuring glutamate and GABA levels in anterior cingulate cortex and supplementary motor area (SMA) of healthy volunteers and patients with Obsessive-Compulsive Disorder (OCD). Within the SMA, trait and clinical measures of compulsive behavior were related to glutamate levels, whereas a behavioral index of habitual control correlated with the glutamate:GABA ratio. OCD patients additionally exhibited elevated glutamate levels and glutamate:GABA ratios in anterior cingulate cortex which also correlated with habitual control. This study highlights important underlying relationships between SMA mechanisms of habitual control relevant to compulsive behavior, common to the healthy sub-clinical and OCD populations. The results also demonstrate additional involvement of anterior cingulate in the balance between goal-directed and habitual responding in OCD.

Resorption von Ferritin im proximalen Konvolut der Rattenniere (nach intratubulärer Applikation durch Mikropunktion)

A 1H Magnetic Resonance Spectroscopy Imaging Study on Prefrontal and Hippocampus in Patients with Depression

Correlation of neurochemical metabolism with memory function in young adult patients with first-episode depression studied with proton magnetic resonance spectroscopy]

Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy

Plasma oxidative stress marker levels related to functional brain abnormalities in first-episode drug-naive major depressive disorder

A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia

Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task

Reduction of higher-order occipital GABA and impaired visual perception in acute major depressive disorder

Myo-inositol, Glutamate, and Glutamine in the Prefrontal Cortex, Hippocampus, and Amygdala in Major Depression

Plasma metabolites were associated with spatial working memory in major depressive disorder

Glutathione and glutamate in schizophrenia: a 7T MRS study

Identification of neurotransmitter imbalances in the cingulate cortex of NMOSD patients using magnetic resonance spectroscopy

Cortical Glutamate and GABA Are Related to Compulsive Behaviour in Individuals with Obsessive Compulsive Disorder and Healthy Controls

0130 Central and Peripheral Markers of Oxidative Stress and Sleep in Mood Disorder: A Pilot MR Spectroscopy Study

The impact of matching for reproductive status on the comparison of magnetic spectroscopic measurements of glutamate and gamma-aminobutyric acid + in the medial prefrontal cortex of women with major depression

Cognitive dysfunction and neurometabolic alternations in major depressive disorder with gastrointestinal symptoms

Awakening to the occupational health problems.

Relationships between diabetes and cognitive impairment.

Resting state and activated brain glutamate–glutamine, brain lactate, cognition, and psychopathology among males with schizophrenia: A 3 Tesla proton magnetic resonance spectroscopic (1H-MRS) study

Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder

Neurobehavioral and Neurochemical Basis of Compulsive Behavior: A 7T Magnetic Resonance Spectroscopy Study in Humans